HomeAI · summaries
Storia in 19 fonti
MRNA cancer drug shows success in curbing melanoma - Taipei Times
US drugmakers Merck and Moderna on Wednesday said a personalized cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a “breakthrough.”The drug, called “intismeran autogene,” is based on the same messenger RNA (mRNA) technology b
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
timesofisrael.com
‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence
News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers
- ·
healio.com
mRNA melanoma vaccine-pembrolizumab combo shows survival gains in late-stage trial
A phase 3 trial found that a combination of intismeran autogene plus pembrolizumab improved recurrence-free and distant metastasis-free survival in patients with high-risk…
